James Healy, Director at Karuna Therapeutics, Inc. (KRTX), sold 312,054 shares at $199.90 ($2.4M) on 2023-01-13, disclosed to the SEC on 2023-01-17.
Open-market sale of $2.4M KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 300,000 | $0 | 0.0% |
| 2 | $199.90 | 6,027 | $1.2M | 50.0% |
| 3 | $199.90 | 6,027 | $1.2M | 50.0% |
| Total | $7.72 avg | 312,054 | $2.4M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |